Is the recurrence rate of early cervical cancer high?

After early treatment, since the cancer cells have not spread to other parts of the body, they will not cause too much damage to the body. In the later stage, if you pay attention to personal hygiene and promote the repair of the cervical mucosa, the prognosis is also very good. Generally, regular check-ups are required after surgery. The recurrence rate of most early cervical cancers is not high, and the survival period is generally long, so generally there is not a big problem. The probability of early recurrence of cervical cancer is very low, generally not exceeding 10%.

How much do drugs for preventing and treating cervical cancer cost?

The price actually refers to the types of viruses that the vaccine can prevent. For example, the bivalent vaccine mainly prevents high-risk HPV16 and 18 virus infections, while the quadrivalent vaccine can prevent 6, 116, and 18 infections. The nine-valent vaccine is based on the quadrivalent vaccine, with the addition of subtypes 3345 and 558. It mainly adds subtypes 52 and 58, which are the most susceptible to Asians. There is no specific antiviral drug for preventing cervical cancer, and commonly used antiviral drugs are ineffective in preventing high-risk HPV infections. Aoping is used to treat chronic cervicitis, cervical erosion, and vaginitis caused by vaginal viral infections, and to prevent cervical cancer.

The difference between bivalent and quadrivalent cervical cancer vaccines

The bivalent vaccine was launched in 2007, mainly targeting high-risk HPV16 and HPV18, and preventing cervical cancer caused by HPV16 and HPV18. The bivalent cervical cancer vaccine is suitable for women aged 9-25, and usually requires three injections. There are currently three types of cervical cancer vaccines on the market, including bivalent vaccine, quadrivalent vaccine, and nine-valent vaccine.